Sept 2 (Reuters) - AspenBio Pharma Inc:
* Says on September 1, co received complaint related to blood based
appendicitis test in development appyscore
* Says complaint includes allegations of fraud and negligent misrepresentation
- SEC filing
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Says on September 1, co received complaint related to blood based
appendicitis test in development appyscore
* Says complaint includes allegations of fraud and negligent misrepresentation
- SEC filing
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.